Trial Profile
Gefitinib with concurrent chemoradiation in locally advanced head and neck cancers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin
- Indications Head and neck cancer
- Focus Therapeutic Use
- 01 Sep 2015 New trial record